A study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print yesterday by the U.S. National Institute of Health (who also conducted the study), has found that cannabinoid agonists – such as cannabis – may attenuate HIV-associated neuro cognitive disorders in HIV patients on HAART (highly active antiretroviral therapy). …
Tag: hiv-associated neuro cognitive disorders
- Vermont and New Hampshire May Delay Votes on Marijuana Proposals
- First-ever First Nation cannabis outdoor grow operation; First Nation cannabis inventor and entrepreneur featured in second edition of “Growth and Prosperity” Magazine
- Wiisag Receives Confirmation of Readiness for Outdoor Cannabis Cultivation
- Arkansas First Ever Medical Marijuana Dispensary Now Open
- Medical Marijuana vs. Recreational Marijuana
- How Does Medicare Cover Arthritis?
- Florida Legislature Approves Bill to Establish Agricultural Hemp Program
- Study: Most Health Professionals (Doctors, Pharmacists and Nurses) Support Medical Marijuana
Thank you for reading TheJointBlog.com!